CJC-1295 w/o DAC 5mg Ipamorelin 5mg

CJC-1295 (a GHRH analog) and Ipamorelin (a selective ghrelin receptor agonist) are often combined to stimulate growth hormone release through complementary mechanisms. Together, they enhance natural GH and IGF-1 production, supporting recovery, fat loss, and lean muscle development. Key Benefits of CJC-1295 • Synergistic GH Release: Stronger and more sustained growth hormone pulses. • Lean Muscle Growth: Supports protein synthesis and recovery. • Fat Reduction: Promotes lipolysis and metabolic balance. • Anti-Aging Support: May improve sleep, skin, and energy levels. Clinical Findings • CJC-1295: Shown to extend half-life of GHRH, leading to sustained GH elevation. • Ipamorelin: Highly selective GHRP with minimal cortisol/prolactin impact. • Combination: Research suggests enhanced GH and IGF-1 secretion when used together. Safety & Tolerability • Generally well tolerated in studies. • Possible mild side effects: flushing, headache, injection site irritation, transient hunger. • Long-term safety data limited. All information provided is for informational and research reference purposes only and should not be interpreted as medical advice. NordWellness makes no claims regarding therapeutic use or outcomes.